Skip to main content

Want a detailed portfolio tracker?

Biodexa Pharmaceuticals (BDRX) P/E (2023 - 2026)

Biodexa Pharmaceuticals (BDRX) P/E from Oct 2, 2023 to Jul 21, 2026. The TTM Biodexa Pharmaceuticals (BDRX) P/E is -1.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Biodexa Pharmaceuticals (BDRX)

YearP/EChange
2026-1.11-84.41%
2025-7.10-94.40%
2024-126.72-93.96%
2023-2.10KN/A

Comparison Biodexa Pharmaceuticals (BDRX) P/E with competitors

Biodexa Pharmaceuticals (BDRX) P/E is -1.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.15%
NBYStablecoin Development Corp0.00-100.39%
ENLVEnlivex Ltd0.07-106.75%
FGENFibroGen Inc0.24-121.67%
CHRSCoherus Biosciences Inc0.85-176.60%
FBIOFortress Biotech Inc0.95-185.68%
ORMPOramed Pharmaceuticals Inc1.50-235.69%
AGENAgenus Inc3.01-371.70%
INVAInnoviva Inc3.15-384.74%
VXRTVaxart Inc3.55-420.46%
CRMDCorMedix Inc3.63-427.57%
CVACCureVac N.V.4.45-501.35%
GLPGGalapagos NV4.86-538.65%
SRPTSarepta Therapeutics Inc4.88-540.75%
ABEOAbeona Therapeutics Inc5.39-586.37%
ABUSArbutus Biopharma Corp5.60-605.16%
ZVRAZevra Therapeutics Inc5.89-631.49%
SPROSpero Therapeutics Inc6.23-662.29%
CGENCompugen Ltd6.31-670.01%
RIGLRigel Pharmaceuticals6.87-720.40%
SLXNSilexion Therapeutics Corp7.30-758.68%
OMEROmeros Corporation9.26-935.86%
AUPHAurinia Pharmaceuticals Inc9.58-965.31%
PLXProtalix BioTherapeutics Inc10.89-1083.22%
ACADAcadia Pharmaceuticals Inc11.73-1158.83%
TBPHTheravance Biopharma Inc12.26-1207.01%
ADMAAdma Biologics Inc12.42-1221.09%
HRMYHarmony Biosciences Holdings Inc13.82-1347.66%
SABSSAB Biotherapeutics Inc14.14-1376.19%
NAGENiagen Bioscience Inc14.82-1437.76%
INCYIncyte Corp15.82-1528.43%
REGNRegeneron Pharmaceuticals Inc15.86-1531.51%
PBYIPuma Biotechnology Inc17.32-1663.23%
CPRXCatalyst Pharmaceuticals Inc17.44-1674.39%
EXELExelixis Inc17.54-1683.30%
TGTXTG Therapeutics Inc18.97-1812.23%
MDXGMimedx Group Inc20.55-1955.45%
XOMAXOMA Royalty Corp22.87-2165.15%
ARGXArgen X SE24.30-2293.64%
CTMXCytomX Therapeutics Inc24.82-2340.87%
XOMAOXOMA Royalty Corp25.34-2388.15%
HALOHalozyme Therapeutics Inc25.62-2413.33%
XOMAPXOMA Royalty Corp25.67-2417.52%
VRTXVertex Pharmaceuticals Inc27.99-2627.39%
RPRXRoyalty Pharma plc - Class A28.69-2689.93%
SLNOSoleno Therapeutics Inc29.02-2719.53%
ASNDAscendis Pharma A/S30.09-2816.15%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3522.73%
APLSApellis Pharmaceuticals Inc39.02-3622.87%
BMRNBiomarin Pharmaceutical Inc42.21-3910.92%
KRYSKrystal Biotech Inc45.34-4193.64%
ONCBeiGene Ltd69.54-6378.17%
PHARPharming Group N.V.75.03-6873.37%
TECHBio-Techne Corp101.96-9304.89%
VCELVericel Corp109.92-10023.79%
ALNYAlnylam Pharmaceuticals Inc117.96-10749.99%
GMABGenmab140.29-12765.57%
TLXTelix Pharmaceuticals Ltd162.15-14739.30%
CORTCorcept Therapeutics Inc212.86-19316.96%